Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Conatus Pharmaceuticals Inc (NASDAQ:CNAT)

7.49
Delayed Data
As of 2:39pm ET
 -0.146 / -1.91%
Today’s Change
1.45
Today|||52-Week Range
8.05
+42.20%
Year-to-Date

Today’s Trading

Previous close7.64
Today’s open7.68
Day’s range7.40 - 7.75
Volume352,203
Average volume (3 months)1,624,672
Market cap$199.9M
Dividend yield--
Data as of 2:39pm ET, 04/25/2017

Growth & Valuation

Earnings growth (last year)-0.77%
Earnings growth (this year)+44.71%
Earnings growth (next 5 years)+74.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales149.38
Price/Book9.16

Competitors

 Today’s
change
Today’s
% change
CEMPCempra Inc0.000.00%
MDGLMadrigal Pharmaceuti...+0.26+1.55%
OBSVObseva SA+0.01+0.19%
CLSDClearside Biomedical...+0.11+1.46%
Data as of 2:37pm ET, 04/25/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$799.0K
Annual profit (last year)-$29.7M
Net profit margin-3,721.12%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Steven J. Mento
Chief Financial Officer, Secretary &
SVP-Finance
Charles J. Cashion
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs